---
figid: PMC7912811__cells-10-00292-g001
figtitle: Gonadotropin releasing hormone (GnRH) receptor signal transduction in endometrial
  cancer (EC)
organisms:
- NA
pmcid: PMC7912811
filename: cells-10-00292-g001.jpg
figlink: pmc/articles/PMC7912811/figure/cells-10-00292-f001/
number: F1
caption: Gonadotropin releasing hormone (GnRH) receptor signal transduction in endometrial
  cancer (EC). Binding of GnRH-I and GnRH-I agonists causes G-protein αi-mediated
  activation of phospho-tyrosine phosphatase (PTP), resulting in dephosphorylated
  EGF-receptor (EGF-R) and inhibition of EGF-R signal transduction through the ERK1/2
  or the PI3K/AKT pathway leading to a reduction of proliferation. GnRH-induced activation
  of PTP also inhibits the signaling cascade of G-protein coupled estrogen receptor
  (GPER) and estrogen receptor α (ERα) through transactivation of EGF-R. In addition,
  GnRH induces activation of NFκB to reduce and FAS-ligand to increase apoptosis.
  Finally, GnRH agonists activate the JNK/AP-1 pathway, resulting in an increased
  G0/1 phase of the cell cycle and decreased DNA-synthesis. Akt, protein kinase B
  (PKB). AP-1, activator protein-1. E2, estradiol. EGF, epidermal growth factor. ERK1/2,
  p44/42 mitogen-activated protein (MAP) kinase. FAS, Fas receptor. FasL, Fas ligand.
  GDP, guanosindiphosphate. GRB2, growth factor receptor-bound protein 2. GTP, guanosintriphosphate.
  HB-EGF, heparin-binding EGF-like growth factor. JNK, c-Jun N-terminale kinase. JunD,
  transcription factor JunD. MEK, mitogen-activated protein kinase kinase (MAP2K).
  MMP, matrix metalloproteinase. NFkB, nucleus factor kB. PI3K, phosphoinositide 3-kinase.
  RAS, G-protein rat sarcoma. SOS, guanine nucleotide exchange factor ”son of sevenless“.
  SRE, serum response element. Src, tyrosine kinase cellular sarcoma. SRF, serum response
  factor. TAM, tamoxifen.
papertitle: The Role of Gonadotropin-Releasing Hormone (GnRH) in Endometrial Cancer.
reftext: Günter Emons, et al. Cells. 2021 Feb;10(2):292.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9653166
figid_alias: PMC7912811__F1
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC7912811__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7912811__cells-10-00292-g001.html
  '@type': Dataset
  description: Gonadotropin releasing hormone (GnRH) receptor signal transduction
    in endometrial cancer (EC). Binding of GnRH-I and GnRH-I agonists causes G-protein
    αi-mediated activation of phospho-tyrosine phosphatase (PTP), resulting in dephosphorylated
    EGF-receptor (EGF-R) and inhibition of EGF-R signal transduction through the ERK1/2
    or the PI3K/AKT pathway leading to a reduction of proliferation. GnRH-induced
    activation of PTP also inhibits the signaling cascade of G-protein coupled estrogen
    receptor (GPER) and estrogen receptor α (ERα) through transactivation of EGF-R.
    In addition, GnRH induces activation of NFκB to reduce and FAS-ligand to increase
    apoptosis. Finally, GnRH agonists activate the JNK/AP-1 pathway, resulting in
    an increased G0/1 phase of the cell cycle and decreased DNA-synthesis. Akt, protein
    kinase B (PKB). AP-1, activator protein-1. E2, estradiol. EGF, epidermal growth
    factor. ERK1/2, p44/42 mitogen-activated protein (MAP) kinase. FAS, Fas receptor.
    FasL, Fas ligand. GDP, guanosindiphosphate. GRB2, growth factor receptor-bound
    protein 2. GTP, guanosintriphosphate. HB-EGF, heparin-binding EGF-like growth
    factor. JNK, c-Jun N-terminale kinase. JunD, transcription factor JunD. MEK, mitogen-activated
    protein kinase kinase (MAP2K). MMP, matrix metalloproteinase. NFkB, nucleus factor
    kB. PI3K, phosphoinositide 3-kinase. RAS, G-protein rat sarcoma. SOS, guanine
    nucleotide exchange factor ”son of sevenless“. SRE, serum response element. Src,
    tyrosine kinase cellular sarcoma. SRF, serum response factor. TAM, tamoxifen.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PolG1
  - pyd
  - hb
  - Egfr
  - Mp
  - Fas1
  - FASN1
  - Fas2
  - Fas3
  - fand
  - tei
  - rg
  - FASN2
  - FASN3
  - Ptp69D
  - Src42A
  - Csk
  - Src64B
  - drk
  - Sos
  - ras
  - Ras64B
  - Ras85D
  - bsk
  - era
  - Dsor1
  - Mtk
  - levy
  - COX6AL2
  - Akt
  - rl
  - Dif
  - dl
  - Rel
  - Elk
  - Srf
  - mal
  - bs
  - kay
  - fo
  - AP-1gamma
  - Jra
  - CycE
  - cyc
  - TAM
  - STIM1
  - GSTM1
  - GNRH1
  - GNRH2
  - EGF
  - EGFR
  - FASLG
  - FAS
  - FASN
  - GPER1
  - SLC25A3
  - REG1A
  - PTPRU
  - SRC
  - FGR
  - FYN
  - YES1
  - GRB2
  - XYLT2
  - SOS1
  - SOS2
  - KRAS
  - HRAS
  - NRAS
  - MAPK8
  - MAPK9
  - MAPK10
  - ESR1
  - ERAL1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - SEMA6A
  - AKT1
  - AKT2
  - AKT3
  - MAPK3
  - MAPK1
  - JUND
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - EPHB1
  - KCNH8
  - OGDH
  - SRF
  - FOS
  - FOSB
  - FOSL1
  - FOSL2
  - JUN
  - JUNB
  - TAM
  - GDP
---
